Insulin sensitivity, insulinemia, and coronary artery disease - The insulin resistance atherosclerosis study

被引:103
作者
Rewers, M
Zaccaro, D
D'Agostino, R
Haffner, S
Saad, MF
Selby, JV
Bergman, R
Savage, P
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr, Denver, CO 80262 USA
[2] Wake Forest Univ, Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA
[3] Univ Texas, Dept Med, San Antonio, TX 78285 USA
[4] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA
[5] Univ So Calif, Dept Physiol & Biophys, Los Angeles, CA USA
[6] Kaiser Res Ctr, Div Res, Oakland, CA USA
[7] NHLBI, Div Epidemiol & Clin Applicat, Bethesda, MD 20892 USA
关键词
D O I
10.2337/diacare.27.3.781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- The aim of this study was to evaluate whether low insulin sensitivity (S;) measured using a modified frequently sampled intravenous glucose tolerance test with minimal model analysis is associated with coronary artery disease (CAD) independent of other cardiovascular risk factors. RESEARCH DESIGN AND METHODS- We studied 1,482 women and men, age 40-69 years old, African American (28%), Hispanic (34%), or non-Hispanic white (38%), with normal (45%), impaired (23%), or diabetic (32%) glucose tolerance. CAD defined as confirmed past myocardial infarction, coronary artery bypass graft, coronary angioplasty, or presence of a major Q-wave was found in 91 participants. RESULTS- The odds ratio (OR) for CAD was greatest among individuals in the two lowest quintiles of S-i (2.4, 95% CI 1.0-5.6 and 4.7, 2.1-10.7) compared with the highest S-i quintile. After adjusting for demographic and cardiovascular risk factors, a decrement from the 75th to 25th percentile in S-i was associated with a 56% increase in CAD (P = 0.028). Similar increments in fasting or 2-h insulin levels were associated with, respectively, only 15 (NS) and 3% (NS) increases in CAD. The association between S-i and CAD was partially mediated by insulin, HDL cholesterol and triglyceride levels, hypertension, diabetes, and obesity, but not LDL cholesterol or cigarette smoking. CONCLUSIONS- Low S-i is associated with CAD independently of and stronger than plasma insulin levels. Part of the association is accounted for by dyslipidemia, hypertension, diabetes, and obesity.
引用
收藏
页码:781 / 787
页数:7
相关论文
共 41 条
[1]  
[Anonymous], 1995, Diabetes in America
[2]   Does hyperglycemia really cause coronary heart disease? [J].
BarrettConnor, E .
DIABETES CARE, 1997, 20 (10) :1620-1623
[3]   ASSESSMENT OF INSULIN SENSITIVITY INVIVO [J].
BERGMAN, RN ;
FINEGOOD, DT ;
ADER, M .
ENDOCRINE REVIEWS, 1985, 6 (01) :45-86
[4]   Insulin resistance and coronary artery disease [J].
Bressler, P ;
Bailey, SR ;
Matsuda, M ;
DeFronzo, RA .
DIABETOLOGIA, 1996, 39 (11) :1345-1350
[5]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[6]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[7]  
ESCHWEGE E, 1985, HORM METAB RES, V15, P41
[8]   INSULIN RESISTANCE IN ESSENTIAL-HYPERTENSION [J].
FERRANNINI, E ;
BUZZIGOLI, G ;
BONADONNA, R ;
GIORICO, MA ;
OLEGGINI, M ;
GRAZIADEI, L ;
PEDRINELLI, R ;
BRANDI, L ;
BEVILACQUA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) :350-357
[9]   A prospective study at coronary heart disease in relation to fasting insulin, glucose, and diabetes - The atherosclerosis risk in communities (ARIC) study [J].
Folsom, AR ;
Szklo, M ;
Stevens, J ;
Liao, FZ ;
Smith, R ;
Eckfeldt, JH .
DIABETES CARE, 1997, 20 (06) :935-942
[10]   Low insulin sensitivity (Si=0) in diabetic and nondiabetic sublects in the insulin resistance Aherosclerosis Study -: Is it associated with components of the metabolic syndrome and nontraditional risk factors? [J].
Haffner, SM ;
D'Agostino, R ;
Festa, A ;
Bergman, RN ;
Mykkänen, L ;
Karter, A ;
Saad, MF ;
Wagenknecht, LE .
DIABETES CARE, 2003, 26 (10) :2796-2803